Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAK-906 for symptomatic idiopathic or diabetic gastroparesis
jRCT2080224145Phase 2Completed
- Sponsor
- Takeda
- Start
- Nov 2018
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of trazpiroben in idiopathic gastroparesis (IG) and diabetic gastroparesis (4 arms), sponsored by Takeda. Primary endpoints: Efficacy in idiopathic and diabetic gastroparesis and Safety and tolerability. Started Nov 2018; status: completed.
02
Drugs
trazpiroben
03
Conditions
idiopathic gastroparesis (IG)diabetic gastroparesis
Beyond the preview
Go deeper on jRCT2080224145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224145.